| Structure | Chemical Name | CAS | MF |
|
2-((3-chlorobenzyl)thio)-1H-benzo[d]imidazole
|
353261-16-2
|
C14H11ClN2S
|
|
N-(3,5-dichlorophenyl)-2-(3-oxo-3,4-dihydro-2H-1,4-benzothiazin-2-yl)acetamide
|
353261-55-9
|
C16H12Cl2N2O2S
|
|
NS-6180
|
353262-04-1
|
C16H12F3NOS
|
|
1-naphthalen-1-yl-3-[2-(trifluoromethyl)phenyl]urea
|
353263-34-0
|
C18H13F3N2O
|
|
2,3,4,6-TETRA-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL TRICHLOROACETIMIDATE
|
353264-42-3
|
C16H20Cl3NO10
|
|
1-(5-(4-bromophenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)ethan-1-one
|
353268-49-2
|
C17H15BrN2O
|
|
4H-Pyran-4-one,2-(2-amino-1-hydroxyethyl)-5-methoxy-(9CI)
|
353268-99-2
|
C8H11NO4
|
|
METHYL 5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHENE-2-CARBOXYLATE
|
353269-02-0
|
C9H10O2S
|
|
Carbamic acid, (2,5-dibromo-3-thienyl)-, 1,1-dimethylethyl ester (9CI)
|
353269-03-1
|
C9H11Br2NO2S
|
|
VERAPAMILETHYL METHANETHIOSULFONATE, BROMIDE
|
353270-25-4
|
C30H45BrN2O6S2
|
|
rac Methyl Efavirenz
|
353270-76-5
|
C15H11ClF3NO2
|
|
Efavirenz IP Impurity A
|
353270-77-6
|
C21H17ClF3NO3
|
|
QUINOLIN DERIVATIVE
|
353271-48-4
|
C29H22ClN3O3
|
|
6-chloro-5-iodopyrimidin-4-amine
|
353272-15-8
|
C4H3ClIN3
|
|
1-Piperidineaceticacid,2-amino-(9CI)
|
353273-56-0
|
C7H14N2O2
|
|
Ingap (104-118)
|
353273-97-9
|
C64H100N20O22
|
|
(2E)-4-[4-(diphenylmethyl)piperazin-1-yl]-4-oxobut-2-enoic acid
|
353276-06-9
|
C21H22N2O3
|
|
6-Chloro-5-nitropyridine-2-carboxylic acid
|
353277-27-7
|
C6H3ClN2O4
|
|
2-(4-CHLORO-PHENYLSULFANYL)-PYRIDIN-3-YLAMINE
|
353277-58-4
|
C11H9ClN2S
|
|
6-[(4-Bromophenyl)sulfanyl]-3-pyridinylamine
|
353277-60-8
|
C11H9BrN2S
|
|
2-broMo-4-MethoxybenzaMide
|
353278-57-6
|
C8H8BrNO2
|
|
[[4-[2-(6-Benzoyl-2-oxo-3(2H)-benzothiazolyl)ethoxy]phenyl]methyl]-1,3-propanedioicaciddimethylester
|
353280-43-0
|
C28H25NO7S
|
|
2-Chloro-3-nitro-4-pyridinecarboxylic acid
|
353281-15-9
|
C6H3ClN2O4
|
|
2-Thiophenecarbonitrile, 5-(1-hydroxyethyl)- (9CI)
|
353282-69-6
|
C7H7NOS
|
|
1-(4-bromo-2-fluorophenyl)ethanol
|
353282-88-9
|
C8H8BrFO
|
|
3-AMino-4,6-diMethyl-thieno[2,3-b]pyridine-2-carboxylic acid naphthalen-1-yl-Methylene hydrazide
|
353287-09-9
|
C21H18N4OS
|
|
Pyrano[2,3-c]pyrazol-6(1H)-one,3,4,5-trimethyl-1-phenyl-
|
353287-46-4
|
C15H14N2O2
|
|
6-(3,4-dimethoxyphenyl)-3-(2-thienyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
|
353287-72-6
|
C15H12N4O2S2
|
|
[1,1',3',1",3",1"'-Quaterphenyl]-3,3'''-dimethylalcohol
|
353289-47-1
|
C27H24O3
|
|
Piperidine-3-carbaldehyde
|
353290-29-6
|
C6H11NO
|
|
α-Methyl-ω-[(tetrahydro-2-furanyl)methoxy]-poly[oxy (methyl-1,2-ethanediyl)]
|
353291-27-7
|
|
|
Acetic acid, [(3-hydroxy-2-pyridinyl)oxy]-, methyl ester (9CI)
|
353292-80-5
|
C8H9NO4
|
|
Acetic acid, [(3-hydroxy-2-pyridinyl)oxy]-, ethyl ester (9CI)
|
353292-81-6
|
C9H11NO4
|
|
Propanoic acid, 2-[(3-hydroxy-2-pyridinyl)oxy]-, methyl ester (9CI)
|
353292-82-7
|
C9H11NO4
|
|
3-(4-chloro-2-fluoro-5-sulfanylphenyl)-1-methyl-6-(trifluoromethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
|
353292-92-9
|
C12H7ClF4N2O2S
|
|
Propanoic acid, 2-[(3-amino-2-pyridinyl)oxy]-, methyl ester (9CI)
|
353293-10-4
|
C9H12N2O3
|
|
Acetic acid, [(5-hydroxy-2-pyridinyl)oxy]-, methyl ester (9CI)
|
353293-42-2
|
C8H9NO4
|
|
BOC-L-BETA-HOMOALANINE ALLYL ESTER
|
353296-84-1
|
C12H21NO4
|
|
IPASE-T
|
353301-20-9
|
|
|
2-Oxetanecarboxylicacid,4-oxo-,ethylester,(2S)-(9CI)
|
353302-29-1
|
C6H8O4
|
|
2-Oxetanecarboxylicacid,2-methyl-4-oxo-,methylester,(2S)-(9CI)
|
353302-31-5
|
C6H8O4
|
|
2-Oxetanecarboxylicacid,2-ethyl-4-oxo-,methylester,(2S)-(9CI)
|
353302-32-6
|
C7H10O4
|
|
2-Oxetanone, 4-acetyl-4-methyl-, (4S)- (9CI)
|
353302-37-1
|
C6H8O3
|
|
2H,5H-Pyrano[4,3-b]pyran-5-one, 3,4-dihydro-3,4-dihydroxy-2,7-dimethyl-, (2R,3S,4S)-rel- (9CI)
|
353449-27-1
|
C10H12O5
|
|
N-(5-chloro-2-methoxyphenyl)-2-(5-methyl-3-nitro-1H-pyrazol-1-yl)acetamide
|
353455-23-9
|
C13H13ClN4O4
|
|
2-(4-chloro-5-methyl-3-nitro-1H-pyrazol-1-yl)-N-(4-chlorobenzyl)acetamide
|
353455-65-9
|
C13H12Cl2N4O3
|
|
Ethanone, 1-[4-bromo-1-(dimethylamino)-2-naphthalenyl]-2-chloro-2,2-difluoro-
|
353457-09-7
|
C14H11BrClF2NO
|
|
4-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]aniline
|
353457-63-3
|
C14H14F3N3
|
|
2-Pyridinecarboxylicacid,1,4-dihydro-5-methoxy-1-methyl-4-oxo-(9CI)
|
353460-76-1
|
C8H9NO4
|
|
N,N'-1,5-Naphthalenediylbis[2-methoxy]acetamide
|
353460-78-3
|
|
|
2-(2,4-dichlorophenoxy)-
|
353464-92-3
|
C21H13Cl3N2O2S
|
|
1-(3-methoxybenzoyl)piperidine-4-carboxylic acid
|
353465-22-2
|
C14H17NO4
|
|
5-bromo-N-(4-phenylbutyl)-2-furamide
|
353466-89-4
|
C15H16BrNO2
|
|
2-Amino-4-[5-(4-chloro-phenyl)-furan-2-yl]-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
|
353466-95-2
|
C22H19ClN2O3
|
|
2-AMino-6-Methyl-4,5,6,7-tetrahydro-thieno[2,3-c]pyridine-3-carboxylic acid tert-butyl ester
|
353467-24-0
|
C13H20N2O2S
|
|
5,5-Bis(hydroxymethyl)-1,3-thiazolidine-2,4-dione
|
353467-32-0
|
C5H7NO4S
|
|
Cyclohexanecarboxamide, N-[5-(1-methylethyl)-1,3,4-thiadiazol-2-yl]- (9CI)
|
353467-82-0
|
C12H19N3OS
|
|
N-(4-Acetylphenyl)-4-(4-chloro-2-methylphenoxy)-butanamide
|
353467-85-3
|
C19H20ClNO3
|
|
N-(3-Acetylphenyl)-4-(4-chloro-2-methylphenoxy)-butanamide
|
353467-86-4
|
C19H20ClNO3
|
|
2-methyl-5-(pyrrolidine-1-sulfonyl)benzoic acid
|
353467-90-0
|
C12H15NO4S
|
|
Benzenesulfonamide, 3-cyano-4-methyl- (9CI)
|
353468-48-1
|
C8H8N2O2S
|
|
2-(3,5-dimethoxybenzamido)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide
|
353468-94-7
|
C19H22N2O4S
|
|
4-[4-(allyloxy)phenyl]-2-amino-1-(4-bromophenyl)-7,7-dimethyl-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarbonitrile
|
353469-64-4
|
C27H26BrN3O2
|
|
4-[4-(allyloxy)phenyl]-2-amino-1-(3-chloro-2-methylphenyl)-7,7-dimethyl-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarbonitrile
|
353469-66-6
|
C28H28ClN3O2
|
|
5,5-DIMETHYL-3-(2-PIPERAZIN-1-YL-ETHYLAMINO)-CYCLOHEX-2-ENONE
|
353470-05-0
|
C14H25N3O
|
|
Cyclopentanecarboxamide, N-(2,4-dimethoxyphenyl)- (9CI)
|
353471-34-8
|
C14H19NO3
|
|
dimethyl 5-{[(1-oxo-1H-isochromen-3-yl)carbonyl]amino}isophthalate
|
353473-84-4
|
C20H15NO7
|
|
2-chloro-N,N-dipropylnicotinamide
|
353474-24-5
|
C12H17ClN2O
|
|
2-Cyclopenten-1-one,4-ethyl-2-hydroxy-3-methyl-5-methylene-(9CI)
|
353475-95-3
|
C9H12O2
|
|
2-Cyclopenten-1-one,5-ethylidene-2-hydroxy-3,4-dimethyl-,(5Z)-(9CI)
|
353475-98-6
|
C9H12O2
|
|
2-Cyclopenten-1-one, 5-ethylidene-2-hydroxy-3-methyl-4-phenyl-, (5Z)- (9CI)
|
353476-01-4
|
C14H14O2
|
|
2-Cyclopenten-1-one,3-bromo-5-ethylidene-2-hydroxy-,(5Z)-(9CI)
|
353476-04-7
|
C7H7BrO2
|
|
2-Cyclopenten-1-one, 3-bromo-5-ethylidene-2-hydroxy-4-methyl-, (5Z)- (9CI)
|
353476-10-5
|
C8H9BrO2
|
|
Morpholine, 4-(2-bromo-1-oxo-2-propenyl)- (9CI)
|
353476-50-3
|
C7H10BrNO2
|
|
2-(3-chlorophenyl)-4,5-dimethoxyisoindoline-1,3-dione
|
353479-21-7
|
C16H12ClNO4
|
|
5-Pyrimidinecarboxamide,4-(4-chlorophenyl)-1,2,3,4-tetrahydro-6-methyl-2-oxo-(9CI)
|
353482-89-0
|
C12H12ClN3O2
|
|
TQS
|
353483-92-8
|
C22H20N2O2S
|
|
4-CHLORO-N-{[1-(3,4-DIMETHOXYPHENYL)CYCLOPENTYL]METHYL}BENZAMIDE
|
353484-20-5
|
C21H24ClNO3
|
|
3H-Cyclopenta[c]quinoline-4,8-dicarboxylic acid, 3a,4,5,9b-tetrahydro-
|
353484-21-6
|
C14H13NO4
|
|
4-(4-bromophenyl)-5-[4-(propan-2-yloxy)benzyl]-4H-1,2,4-triazole-3-thiol
|
353484-34-1
|
C18H18BrN3OS
|
|
CHEMBRDG-BB 5667569
|
353484-61-4
|
C16H17NO4
|
|
Thieno[3,2-c]pyridine-2-carbonitrile, 3-amino-5-ethyl-4,5,6,7-tetrahydro- (9CI)
|
353486-58-5
|
C10H13N3S
|
|
8aH-Pyrrolo[3,2-e][1,2,3]benzoxadiazol-8a-ol, 4,5,5a,6,7,8-hexahydro-6-hydroxy-, 2-oxide (9CI)
|
353487-23-7
|
C8H11N3O4
|
|
2-Benzothiazolecarboxylicacid,5-amino-
|
353487-33-9
|
C8H6N2O2S
|
|
3-Propanoyl-5-bromo-benzo[b]thiophene
|
353487-39-5
|
C11H9BrOS
|
|
AC-ARG-CYS-MET-5-AMINOPENTANOYL-ARG-VAL-TYR-5-AMINOPENTANOYL-CYS-NH2, (DISULFIDE BOND) TRIFLUOROACETATE
|
353487-64-6
|
C49H82N16O11S3
|
|
N-(AMINOTHIOXOMETHYL)-PYRIDINE-4-CARBOXAMIDE
|
353492-16-7
|
C7H7N3OS
|
|
Tricyclo[3.3.1.13,7]decane-1-carboxamide, N-[1-methyl-2-[(2-methylphenyl)amino]-2-oxoethyl]- (9CI)
|
353492-17-8
|
C21H28N2O2
|
|
Tricyclo[3.3.1.13,7]decane-1-carboxamide, N-[2-[(4-methoxyphenyl)amino]-1-methyl-2-oxoethyl]- (9CI)
|
353492-18-9
|
C21H28N2O3
|
|
2-Azetidinecarboxaldehyde,1-(3-butenyl)-3-methoxy-4-oxo-,(2R,3R)-(9CI)
|
353494-37-8
|
C9H13NO3
|
|
3a,4,5,9b-Tetrahydro-8-nitro-4-(3-nitrophenyl)-3H-cyclopenta[c]quinoline
|
353495-22-4
|
C18H15N3O4
|
|
1-BOC-4-(CBZ-AMinoMethylcarbonyl)piperazine
|
353495-62-2
|
C19H27N3O5
|
|
10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxylicacidMethylester
|
353497-31-1
|
C16H13NO3
|
|
Imidazo[1,2-a]pyrazin-3(7H)-one, 6-[4-[[(1,1-dimethylethyl)diphenylsilyl]oxy]phenyl]-2-[(4-hydroxyphenyl)methyl]-8-
|
353497-34-4
|
C42H39N3O3Si
|
|
2-Benzofurancarboxaldehyde,6-ethoxy-3-methyl-(9CI)
|
353497-67-3
|
C12H12O3
|
|
N-(3,5-DIMETHYLPHENYL)-N-(METHYLSULFONYL)GLYCINE
|
353502-16-6
|
C11H15NO4S
|
|
5-(2-METHYL-5-NITRO-PHENYL)-FURAN-2-CARBOXYLIC ACID
|
353504-04-8
|
C12H9NO5
|
|
2-Furancarboxylic acid, 5-(1H-indazol-3-yl)-, methyl ester
|
353504-12-8
|
C13H10N2O3
|
|
2-Furancarboxylic acid, 5-(2-nitrobenzoyl)-, methyl ester
|
353504-65-1
|
C13H9NO6
|
|
Carbamic acid, [4-(formylamino)butyl]-, 1,1-dimethylethyl ester (9CI)
|
353505-01-8
|
C10H20N2O3
|